Evaluation of a community pharmacy reimbursement model for cognitive services-experiment and survey

Journal of Pharmaceutical Finance, Economics and Policy

Volumn 13, Issue 1, 2004, Pages 69-94

  Lopatka, Harold ^a   Bachynsky, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cognitive services; Community pharmacy services; Payment model and system; Pharmacists perceptions; Reimbursement mechanisms

Indexed keywords

DRUG COST; DRUG UTILIZATION; ECONOMIC ASPECT; EXPERIMENTAL DESIGN; INTERVIEW; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; REIMBURSEMENT; REVIEW; TRAINING;

EID: 5444232402     PISSN: 15385698     EISSN: None     Source Type: Journal    
DOI: 10.1300/J371v13n01_06     Document Type: Review

References (32)

1. Raisch, DW. Barriers to providing cognitive services. American Pharmacy. 1993; NS33(12):54-8.
2. Pharmacy Practice. A report from the trenches. Pharmacy Practice. 1996; 12 (12):25-41.
3. Altimed. The Altimed CFP report on pharmacy services 1998 - Private payers' perceptions of pharmacy. Toronto, ON; 1998.
4. McDonald S, Lopatka H, Bachynsky J et al. Systematic review of pharmacy review literature. Working paper 99-4, Institute of Health Economics, Edmonton, AB; 1999.
5. Christensen DB, Holmes GH. Payment of pharmacists for cognitive services - Results of the Washington State C.A.R.E. demonstration project. Contract No. 11-C-90229. Washington, DC: Health Care Financing Administration; 1996.
6. Christensen DB, Holmes G, Fassett WE et al. Influence of a financial incentive on cognitive services: CARE project design/implementation. Journal of the American Pharmaceutical Association. 1999; 39(5):629-39.
7. McCormack J, Reinhardt G, Hastings J et al. Documented value - Arkansas study shows pharmacists who get paid document more interventions. NARD Journal. 1996; March:39-41.
8. Bradley D. The Saskatchewan trial prescription program. Unpublished master's project, University of Saskatchewan, Saskatoon, SK; 1998.
9. Smith F. General Motors pharmacist intervention study (Executive Summary). Nera Communications. London, ON; 1997.
10. Yesalis CE, Norwood GJ, Lipson DP et al. Capitation payment for pharmacy services: Impact on generic substitution. Medical Care. 1980; 18:816-28.
11. Lipson DP, Yesalis CE, Kohout FJ et al. Capitation payment for Medicaid pharmacy services: impact on non-Medicaid prescriptions. Medical Care. 1981; 19:342-53.
12. Helling DK, Yesalis CE, Norwood J et al. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behaviour: I. Prescription quantity and dose analysis. Drug Intelligence and Clinical Pharmacy. 1981; 15:581-9.
13. Norwood GJ, Helling DK, Burmeister LF et al. Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behaviour: II. Therapeutic category analysis, over-the-counter drug usage, and drug interactions. Drug Intelligence and Clinical Pharmacy. 1981; 15:656-64.
14. Yesalis CE, Lipson DP, Norwood J et al. Capitation payment for pharmacy services: I. Impact on drug use and pharmacist dispensing behaviour. Medical Care. 1984;22:737-45.
15. Yesalis CE, Norwood J, Helling DK et al. Capitation payment for pharmacy services: II. Impact on costs. Medical Care. 1984; 22:746-54.
16. Poirier S, Gariepy Y. Compensation in Canada for resolving drug-related problems. Journal of American Pharmaceutical Association. 1996; NS36(2):117-22.
17. Christensen DB, Hansen RW. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting. Journal of the American Pharmaceutical Association. 1999; 39(5):640-9.
18. Cirn JT. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid Drug program. Contemporary Pharmacy Practice. Summer 1980; 3(3):180-8.
19. Dumas J. Part I - Perceptions of the pharmaceutical opinion by community pharmacists in Quebec (Report to Ministry of Health and Social Services). Quebec: Laval University; 1994.
20. Christensen DB. The Washington State health care financing administration cognitive services demonstration. Journal of Research in Pharmaceutical Economics. 1996; 8(1):161-70.
21. Hatoum HT, Akhras K. 1993 Bibliography: A 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Annals of Pharmacotherapy. 1993; 27:1106-19.
22. MacKeigan LD, Segal, HJ, Coyte PC. Post study interview questions. Alternative reimbursement project. For the Joint Task Force of the Ontario Ministry of Health and the Ontario Pharmacists' Association; 1995.
23. Raisch DW. Barriers to providing cognitive services. American Pharmacy. 1993; NS33(12): 54-8.
24. Lopalka H, Bachynsky J. Prescription watch 1999: A one-day prescription intervention study. Canadian Pharmaceutical Journal. 1995; 128(3):27-31,52.
25. Rupp MT, Deyoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Medical Care. 1992; 30(10):926-40.
26. Knapp KK, Katzman H, Hamright JS et al. Community pharmacist interventions in a capitated pharmacy benefit contract. Am J Health-Syst Pharm. 1998; 55: 1141-5.
27. Poston J, Kennedy R, Waruszynski B. Initial results from the community pharmacist intervention study. Canadian Pharmaceutical Journal. 1995; 127(10):18-25.
28. Janke KK, MacLeod-Richards CJ. Initiating practice change - Analysing pharmacy systems and optimizing dispensary functioning. Canadian Pharmaceutical Journal. 1997; 130 (2):37-8, 40.
29. Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. Journal of the American Pharmaceutical Association. 1997; NS37(5):535-42.
30. Grootendorst P, Goldsmith L, Hurley J et al. Financial incentives to dispense low-cost drugs: A case study of British Columbia Pharmacare (paper 96-8). Hamilton: McMaster University, Centre for Health Economics and Policy Analysis; 1996.
31. Tamblyn R, Battista R. Changing clinical practice: Which interventions work? Journal of Continuing Education in the Health Professions. 1993; 13: 273-88.
32. Loh EA, Waruszynski B, Poston J. Cost savings associated with community pharmacist interventions in Canada. Canadian Pharmaceutical Journal. 1996; Feb: 43-55.